SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

Attention is centered on BlackBerry QNXs positioning in physical AI and robotics, particularly its integration with Sift for near-real-time sensor and telemetry analysis, alongside anticipation of the upcoming earnings report. Traders are broadly bullish on QNX partnerships, backlog and potential growth, while skeptics question whether revenue growth and management execution will validate the narrative.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves proposed convertible-note offering and ATM share-sale program are driving attention, with traders focused on added leverage, potential dilution, and the timing of the capital raise. Bulls argue the financing will support expansion amid strong compute demand and new customer commitments, while skeptics question the companys debt burden and shareholder economics.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp Nasdaq-100 rebound despite the Federal Reserves rate hike has put QQQ in focus, with falling Treasury yields and oil prices supporting growth and AI stocks. Traders debate whether the move reflects bullish dip-buying and short covering or an options- and algorithm-driven bounce vulnerable to higher-for-longer rates, the Bank of Japans policy decision, and geopolitical risks.

Arbitrum is one of the leading Ethereum scaling solutions bringing cheap transactions to tens of thousands of users in an environment that feels very similar to Ethereum. It is an optimistic rollup and the leading L2 in terms of TVL. Some of the largest dApps live on Arbitrum include GMX, Radiant, Uniswap V3, and Gains Network.

Arbitrum

Robinhoods use of Arbitrum for its chain and tokenized-asset activity is driving attention, with traders highlighting rising transaction volume, fees, and potential revenue sharing with ARB. The community is broadly bullish on adoption and tokenization, though critics argue unlocks and weak token value capture could limit benefits for holders.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

Ryan Cohens reported purchase of 1 million GameStop shares is driving bullish attention, alongside heavy call activity and speculation that buybacks or options-related hedging could amplify the move. Traders are divided between expecting a short squeeze, possible Roaring Kitty activity, or further upside and those questioning the lack of a new company announcement and the stocks low volume.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Uncertainty surrounding Dutch Bros planned Salad and Go site acquisition has been linked to the stocks sharp selloff and repeated 52-week lows, with traders also focusing on its still-high valuation, consumer pressure, and potential dilution. Bulls view the decline as an overreaction and cite continued store expansion, strong traffic, and growth, while bears argue slowing growth and higher costs justify further repricing.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

Federal Reserve rate-hike expectations are driving attention toward SOFI, with traders debating whether higher funding costs and credit pressure outweigh the benefit of the companys guidance already incorporating two hikes. The reaction is broadly bearish amid continued frustration over weak share performance, dilution, and management, although some bulls argue the hike is already priced in and that SoFis growth remains intact.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Middle East conflict-related supply risks are driving attention, with traders focused on attacks affecting Saudi oil infrastructure, disruption around the Strait of Hormuz, and diesel shortages. The community is split between bullish views that prolonged outages could tighten physical supply and bearish views that a ceasefire, restored pipeline flows, or demand destruction would send oil lower.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.

Cardano

A sharp ADA rebound has traders watching for a breakout above nearby resistance amid broader crypto and altcoin momentum, with some attributing the move to short covering, whale accumulation, or speculation around regulation and Cardano upgrades. The community remains divided, with bullish traders expecting a larger run while skeptics describe the move as a speculative pump lacking a confirmed fundamental catalyst.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Merck and Modernas positive Phase 3 personalized cancer-vaccine results are driving attention, as traders view Personalis genomic technologyand Tempus planned acquisition of the companyas validation of its precision-oncology strategy. The move has also fueled speculation about a short- and gamma squeeze, while some traders warn that the rally is overextended and vulnerable to profit-taking.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TWST Stock Hits Multi-Year High, But ‘Pharma Bro’ Martin Shkreli Calls Twist A Short

Twist Bioscience is drawing attention after joining Eli Lillys TuneLab AI drug-discovery platform as a preferred provider of antibody characterization data, alongside a bullish analyst upgrade citing its exposure to AI-enabled drug discovery. Traders are largely celebrating the momentum and multi-year highs, while bearsincluding Martin Shkreliargue the rally is overextended and worth shorting.

Equity

Twist traded as high as $163.70 on Thursday and finished the session about 9% higher near $156. 


HAE, TWST Stocks Jump To Over 5-Year Highs – What’s Driving The Gains Today?

Haemonetics and Twist Bioscience stocks surged to more than five-year highs on Thursday, as fresh growth opportunities drew cheer from Wall Street.

Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced an agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (Lilly). Twist is a provider of antibody characterization data services for...

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030

AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030 PR Newswire AUSTIN, Texas, Sept. 3, 2026 AUSTIN, Texas, Sept. 3, 2026 /PRNewswire/ -- Equity Insider News Commentary - Pharmaceutical research is being rebuilt...

SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Wood’s ARK Backs Personalized Cancer-Vaccine Future 

ARK sees a path toward custom cancer treatments for every patient, though current costs of $200,000-$300,000 remain a major hurdle.

Twist Bioscience Stock Resilient Despite Scorpion Capital Short Report

TWST shares surge after Anthropic names the company an independent evaluator in a new AI-driven protein design campaign. The bullish momentum overshadows a critical short report published on X by activist short-seller Scorpion Capital.read more...

Twist Bioscience Stock Hits 52-Week High - Here's Why

Twist Bioscience (TWST) stock jumped 17% after Anthropic chose the firm to test AI-designed proteins. Get the full market update.read more...

‘Pharma Bro’ Martin Shkreli Slams Anthropic’s Claude Drug-Discovery Claims: ‘This Is Not Impressive Work’

Claude-designed proteins successfully bound to 14 of 15 targets in independent testing by Adaptyv Bio and Twist Bioscience. 

Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock

Twist Bioscience Corporation (Nasdaq: TWST) (Twist), a mid-cap growth and value biotech company, today announced the pricing of an upsized underwritten public offering of 3,125,000 shares of its common stock at a price to the public of $96.00 per share. All of the shares of common stock to be sold...

Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock

Twist Bioscience Corporation (Nasdaq: TWST) (Twist), a mid-cap growth and value biotech company, today announced the commencement of an underwritten public offering of $250.0 million of shares of its common stock. In addition, Twist intends to grant the underwriters a 30-day option to purchase up...

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Twist Bioscience Corp

Bullish Sentiment

No more this year

One more

Two more

The Federal Reserve raised interest rates by a quarter point to a range of 3.75%-4.00% on Wednesday, its first hike since July 2023, but Fed Chair Kevin Warsh signaled the tightening cycle isn't over. How many more rate hikes do you expect by the end of 2026? Vote and explain your reasoning in the comments.

The Fed hiked rates 25bps yesterday, its first since 2023, but signaled it&#39;s not done - projections point to one or two more hikes this year. How many total hikes do you expect by year-end?

Stocktwits

The Fed hiked rates 25bps yesterday, its first since 2023, but signaled it's not done - projections point to one or two more hikes this year. How many total hikes do you expect by year-end?

Stocktwits Polls

The stock is rallying on a strategic partnership with Lilly TuneLab to provide AI-driven antibody characterization data.

Momentum continues as shares hit multi-year highs, drawing significant attention from traders tracking the biotech sector's latest breakout.

Current Price	$155.56
Prev Close	$143.07
Open	$151.43
Dividend Yield	0.00%
50-Day Moving Average	$116.84
Beta	2.29
Avg. Volume	1.8M
PE Ratio	-69.96

52-Week High	$163.70
52-Week Low	$23.30
Market Capitalization	$9.42B
EPS (Annual)	-$1.30
Price to Book	21.87
Revenue Per Employee	$384,649.64

Feed

News

Sentiment

Earnings

Fundamentals

Info

TWST Fundamentals